Skip to content

Emotional Evaluation and Reconstructed Breast Satisfaction

Emotional Evaluation and Reconstructed Breast Satisfaction After Breast Cancer Treatment: Breast Q Questionary

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03777852
Enrollment
110
Registered
2018-12-17
Start date
2019-07-01
Completion date
2022-02-28
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Neoplasm of the Breast

Keywords

breast cancer, breast surgery, breast reconstruction,

Brief summary

Data from the National Cancer Institute (Inca) reveal that breast cancer is the most common type of cancer among women worldwide. In Brazil, it is second only to non-melanoma skin cancer. Breast cancer is a feared disease in the female universe because it is considered one of the major causes of death due to neoplasia among women. It brings also the stigma of suffering, mutilation, loss of female identity and loss of body contour. Among other issues, problems with body self-image may have an impact on sexuality and fertility, and also, the incapacity to breastfeed. Breast reconstruction can restore the patient's shape and physical integrity, among other benefits. The research justifies itself because information about the satisfaction of breast reconstruction can be achieved. It is also known that women having breast reconstruction after a mastectomy due to cancer have a favorable evolution. This study will analyze body contour satisfaction of women undergoing mastectomy and breast reconstruction as part of their breast cancer treatment. The Breast Q questionnaire will be used to measure patients satisfaction.

Detailed description

This is a prospective, quasi-experimental study. The subject sample will be composed of women submitted to mastectomy due to breast cancer and to breast reconstruction as part of their treatment. They will be evaluated twice. One when they receive the cancer diagnosis and the other six months after de reconstruction surgery. On both occasions, they will answer the Brest Q questionnaire.

Interventions

DIAGNOSTIC_TESTFirst Questionnaire application

Women with breast cancer will respond to the First Breast Q questionnaire before treatment with breast cancer reconstruction surgery.

DIAGNOSTIC_TESTSecond Questionnaire application

Women with breast cancer will respond to the Second Breast Q questionnaire after treatment with breast cancer reconstruction surgery.

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Intervention model description

A group of women will be evaluated twice, being one before the intervention and the second after the breast cancer reconstruction surgery

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* women over eighteen years of age; * women with proven histological diagnosis of breast cancer; * women who have an indication of mastectomy as part of their treatment; * women who have breast reconstruction, regardless of the technique used, as part of their treatment; * women under 70 years of age at the time of the reconstructive surgery

Exclusion criteria

* women diagnosed with breast cancer and treated with conservative surgeries; * women who refuse reconstruction as part of treatment; * women who refused surgery as part of the treatment for breast cancer

Design outcomes

Primary

MeasureTime frameDescription
Post-treatment SatisfactionSix monthComparison of results between the first and the second Breast Q score. This score represents questionnaries about diferents domains and each question has four possible dimensions. The values of these dimensions varies from 1 to 4 (Likert Scale). The sum of each domain raw score scale will be plotted in the Breast Q Conversion Table to convert the summed domain score to a Equivalent Rasch Transformed Score with values ranging from 0 (worst) to 100 (best).

Countries

Brazil

Contacts

Primary ContactHelio HA Carrara, MD, PhD
carrara@fmrp.usp.br551636021000
Backup ContactFrancisco JC Reis, MD, PhD
fjcreis@fmrp.usp.br551636022589

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026